Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Change In Other Working Capital

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Change-In-Other-Working-Capital" stands at 48.67 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -188.01 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -188.01 Billion Japanese Yens.
The 3 year change is -137.89 Billion Japanese Yens.
The 5 year change is 50.28 Billion Japanese Yens.

The Serie's long term average value is 59.94 Billion Japanese Yens. It's latest available value, on 06/30/2024, is -11.27 Billion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 03/31/2022, to it's latest available value, on 06/30/2024, is +114.96 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 03/31/2021, to it's latest available value, on 06/30/2024, is -211.62 Billion.

Change In Other Working Capital for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Change In Other Working Capital905,699,262,464.00
LogoJohnson & Johnson - Change In Other Working Capital486,508,953,600.00
LogoAbbVie Inc - Change In Other Working Capital399,570,305,024.00
LogoRoche Holding AG - Change In Other Working Capital317,433,206,677.55
LogoAstraZeneca PLC - Change In Other Working Capital280,205,508,085.11